Gynaecological Cancers
Biology and Therapeutics
Nonfiction, Health & Well Being, Medical, Specialties, Gynecology & Obstetrics
| Author: | ISBN: | 9781107779907 | |
| Publisher: | Royal College of Obstetricians and Gynaecologists (RCOG) | Publication: | June 1, 2011 |
| Imprint: | Cambridge University Press | Language: | English |
| Author: | |
| ISBN: | 9781107779907 |
| Publisher: | Royal College of Obstetricians and Gynaecologists (RCOG) |
| Publication: | June 1, 2011 |
| Imprint: | Cambridge University Press |
| Language: | English |
Gynaecological cancers are categorised as 'rare' diseases, although collectively they affect over 16,000 women each year in the UK alone. There is a lack of real understanding of these conditions compared with other malignancies, possibly owing to their relative rarity when viewed as individual diseases. The 60th RCOG Study Group brought together a range of experts to examine as many biological aspects of gynaecological cancers as possible, including both surgical and non-surgical therapies. This book presents the findings of the Study Group, with contents including: • current understanding of the biology of gynaecological cancers • translation of biology to the clinic • state of the art in imaging and therapy • current clinical trials • advances in multimodal therapy • individualised treatment.
Gynaecological cancers are categorised as 'rare' diseases, although collectively they affect over 16,000 women each year in the UK alone. There is a lack of real understanding of these conditions compared with other malignancies, possibly owing to their relative rarity when viewed as individual diseases. The 60th RCOG Study Group brought together a range of experts to examine as many biological aspects of gynaecological cancers as possible, including both surgical and non-surgical therapies. This book presents the findings of the Study Group, with contents including: • current understanding of the biology of gynaecological cancers • translation of biology to the clinic • state of the art in imaging and therapy • current clinical trials • advances in multimodal therapy • individualised treatment.
